Status:
COMPLETED
Dosimetric Validation of Scans Generated by GAN From Pre-therapeutic MRI in Stereotactic Cerebral Radiotherapy
Lead Sponsor:
University Hospital, Brest
Conditions:
Brain Metastases
Eligibility:
All Genders
18+ years
Brief Summary
Stereotactic radiotherapy (SRT) is being widely accepted as a treatment of choice for patients with a small number of brain metastases and an acceptable size, allowing a better target dose conformity ...
Eligibility Criteria
Inclusion
- age ≥ 18 years old
- SRT treatment for one or more brain metastasis(ses)
- brain MRI and planning CT scans realized less than 14 days prior to the treatment delivery
Exclusion
- MRI's field of view (FOV) judged insufficient for tumour(s) and OAR visualization
Key Trial Info
Start Date :
July 16 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 17 2020
Estimated Enrollment :
184 Patients enrolled
Trial Details
Trial ID
NCT04525053
Start Date
July 16 2020
End Date
August 17 2020
Last Update
August 25 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHRU de Brest
Brest, France, 29609